Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases

被引:50
|
作者
Nishiguchi, Gisele A. [1 ]
Atallah, Gordana [1 ]
Bellamacina, Cornelia [1 ]
Burger, Matthew T. [1 ]
Ding, Yu [1 ]
Feucht, Paul H. [2 ]
Garcia, Pablo D. [2 ]
Han, Wooseok [1 ]
Klivansky, Liana [1 ,2 ,3 ]
Lindvall, Mika [1 ]
机构
[1] Novartis Inst BioMed Res, Global Discovery Chem Oncol & Exploratory Chem, Emeryville, CA 94608 USA
[2] Novartis Inst BioMed Res, Oncol Res, Emeryville, CA 94608 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA
关键词
Pim-kinase inhibitors; Indole; Kinase selectivity; Oncology; PROTOONCOGENE PIM-1; BINDING MODE; CELL; CANCER; PROGRESSION; TUMORIGENESIS; EXPRESSION; APOPTOSIS; LYMPHOMA; SURVIVAL;
D O I
10.1016/j.bmcl.2011.08.105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 3,5-disubstituted indole derivatives as potent and selective inhibitors of all three members of the Pim kinase family is described. High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold. Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compounds against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC(50) <= 2 nM and Pim-2: IC(50) <= 100 nM). (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6366 / 6369
页数:4
相关论文
共 50 条
  • [41] Identification of novel and specific Pim-1 kinase inhibitors with potent anticancer activity in hematological and solid tumor malignancies
    Brzozka, Krzysztof
    Czardybon, Wojciech
    Kaczorowska, Katarzyna
    Zarebski, Adrian
    Smagur, Jan
    Beuzen, Nicolas
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [42] The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors
    Wang, Hui-Ling
    Cee, Victor J.
    Chavez, Frank, Jr.
    Lanman, Brian A.
    Reed, Anthony B.
    Wu, Bin
    Guerrero, Nadia
    Lipford, J. Russell
    Sastri, Christine
    Winston, Jeff
    Andrews, Kristin L.
    Huang, Xin
    Lee, Matthew R.
    Mohr, Christopher
    Xu, Yang
    Zhou, Yihong
    Tasker, Andrew S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 834 - 840
  • [43] New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation
    Oyallon, Bruno
    Brachet-Botineau, Marie
    Loge, Cedric
    Robert, Thomas
    Bach, Stephane
    Ibrahim, Sajida
    Raoul, William
    Croix, Cecile
    Berthelot, Pascal
    Guillon, Jean
    Pinaud, Noel
    Gouilleux, Fabrice
    Viaud-Massuard, Marie-Claude
    Denevault-Sabourin, Caroline
    MOLECULES, 2021, 26 (04):
  • [44] Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells
    Pierre, Fabrice
    Regan, Collin F.
    Chevrel, Marie-Claire
    Siddiqui-Jain, Adam
    Macalino, Diwata
    Streiner, Nicole
    Drygin, Denis
    Haddach, Mustapha
    O'Brien, Sean E.
    Rice, William G.
    Ryckman, David M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3327 - 3331
  • [45] More than just a GPCR ligand: structure-based discovery of thioridazine derivatives as Pim-1 kinase inhibitors
    Li, Wei
    Wan, Xiaobo
    Zeng, Fanqi
    Xie, Yuting
    Wang, Yanli
    Zhang, Wei
    Li, Li
    Huang, Niu
    MEDCHEMCOMM, 2014, 5 (04) : 507 - 511
  • [46] Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
    Martinez-Gonzalez, Sonia
    Rodriguez-Aristegui, Sonsoles
    Gomez de la Oliva, Cristina Ana
    Isabel Hernandez, Ana
    Gonzalez Cantalapiedra, Esther
    Varela, Carmen
    Belen Garcia, Ana
    Rabal, Obdulia
    Oyarzabal, Julen
    Bischoff, James R.
    Klett, Javier
    Isabel Albarran, Maria
    Cebria, Antonio
    Ajenjo, Nuria
    Garcia-Serelde, Beatriz
    Gomez-Casero, Elena
    Cuadrado-Urbano, Manuel
    Cebrian, David
    Blanco-Aparicio, Carmen
    Pastor, Joaquin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 : 87 - 109
  • [47] Design, synthesis and biological evaluation of novel C3-functionalized oxindoles as potential Pim-1 kinase inhibitors
    Sun, Hong-bao
    Wang, Xiao-yan
    Li, Guo-bo
    Zhang, Li-dan
    Liu, Jie
    Zhao, Li-feng
    RSC ADVANCES, 2015, 5 (37) : 29456 - 29466
  • [48] Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors
    Saluste, Gustavo
    Albarran, Maria I.
    Alvarez, Rosa M.
    Rabal, Obdulia
    Angel Ortega, Miguel
    Blanco, Carmen
    Kurz, Guido
    Salgado, Antonio
    Pevarello, Paolo
    Bischoff, James R.
    Pastor, Joaquin
    Oyarzabal, Julen
    PLOS ONE, 2012, 7 (10):
  • [49] New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
    Lopez-Ramos, Miriam
    Prudent, Renaud
    Moucadel, Virginie
    Sautel, Celine F.
    Barette, Caroline
    Lafanechere, Laurence
    Mouawad, Liliane
    Grierson, David
    Schmidt, Frederic
    Florent, Jean-Claude
    Filippakopoulos, Panagis
    Bullock, Alex N.
    Knapp, Stefan
    Reiser, Jean-Baptiste
    Cochet, Claude
    FASEB JOURNAL, 2011, 25 (05): : 1775 - 1775
  • [50] DISCOVERY OF NEW THIOPHENE, PYRAZOLE, ISOXAZOLE DERIVATIVES AS ANTITUMOR, c-Met, TYROSINE KINASE AND Pim-1 KINASE INHIBITORS
    Mohareb, Rafat Milad
    Hilmy, Khalid M. H.
    Elshehawy, Yasser Abdelaziz
    BULLETIN OF THE CHEMICAL SOCIETY OF ETHIOPIA, 2018, 32 (02) : 285 - 308